Altria Group (MO) Looks 2% Overvalued As Investors Weigh Its Smoke Free Shift

Altria Group, Inc.

Altria Group, Inc.

MO

0.00

Altria Group (MO) is in focus as it continues expanding smoke free nicotine offerings alongside its long standing cigarette and oral tobacco portfolio, prompting investors to reassess how this product mix fits current income and value expectations.

At a share price of US$71.87, Altria Group has seen strong recent momentum, with a 90 day share price return of 9.52% and a year to date share price return of 25.41%, backed by a 1 year total shareholder return of 32.02% and a 5 year total shareholder return of 126.06%. This performance frames the ongoing shift toward smoke free products as part of a broader rerating in how investors view its income and risk profile.

If Altria Group’s track record has you thinking about where else income and stability might meet future themes, it could be worth scanning 18 top founder-led companies

After a strong run in Altria Group’s share price, some income focused investors may wonder whether to add exposure now or wait for a pullback, which makes the current valuation worth a closer look.

Most Popular Narrative: 2% Overvalued

Compared with the most followed fair value estimate of $70.36, Altria Group’s last close at $71.87 sits slightly higher, which puts more focus on what is baked into that narrative.

Analysts expect earnings to reach $9.7 billion (and earnings per share of $5.92) by about June 2029, up from $8.0 billion today. The analysts are largely in agreement about this estimate.

Want to see what is driving that earnings step up for Altria Group? The narrative leans heavily on steadier margins, modest revenue progress, and a re rated profit multiple. The crucial levers are all quantified in detail, but the exact mix might surprise you.

Result: Fair Value of $70.36 (OVERVALUED)

However, the consensus hinges on risks such as tougher e vapor competition and regulatory setbacks for NJOY, which could challenge Altria Group’s margin and earnings assumptions.

Another View: SWS DCF Signals a Very Different Picture

While the analyst narrative for Altria Group points to a fair value of $70.36 and labels the stock as slightly overvalued at $71.87, the SWS DCF model comes to a very different conclusion, with an estimated future cash flow value of $132.17, which implies that Altria Group is heavily undervalued. When two approaches disagree this much, which one do you treat as your anchor?

MO Discounted Cash Flow as at Jul 2026
MO Discounted Cash Flow as at Jul 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Altria Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 46 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Given the mixed signals around Altria Group, this is a moment to move beyond headlines, review the full data set, and decide what holds up for you in terms of income, valuation, and risk reward balance, starting with 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond Altria Group?

If Altria Group has sharpened your focus on income, valuation, and risk, do not stop here. The next opportunity you need to see might be just a screener away.

  • Target reliable income potential by reviewing companies in the 8 dividend fortresses that may align with your yield and stability goals.
  • Hunt for mispriced quality by scanning the screener containing 20 high quality undiscovered gems that could fit a long term, fundamentals first approach.
  • Prioritize resilience by checking stocks in the 80 resilient stocks with low risk scores that may suit a more defensive part of your portfolio.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.